Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Venous Diseases

  • 1
    News

    FDA approves Doptelet for liver disease patients undergoing procedures

    May 22, 2018

    Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure.

  • 1
    News

    Controversy surrounds calf vein thrombosis treatment

    January 30, 2018

    CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.

  • 1
    News

    Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk

    December 6, 2017

    The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.

  • 1
    News

    Infections increase risk of idiopathic VTE

    November 8, 2017

    Beware the increased risk of VTE in patients with infections.

  • 1
    News

    Atrial fibrillation boosts VTE risk

    October 31, 2017

    BARCELONA – Study shows women face higher and more persistent risk.

  • 1
    News

    Caprini score is not a good predictor of PE in patients with DVT

    October 25, 2017

    Commonly used model failed to predict pulmonary embolism in patients with DVT.

  • 1
    News

    Wait at least 2 days to replace central venous catheters in patients with candidemia

    October 15, 2017

    SAN DIEGO – It likely will reduce 30-day mortality.

  • 1
    News

    Oral anticoagulation ‘reasonable’ in advanced kidney disease with A-fib

    October 5, 2017

    Reduced stroke risk, no increase in bleeding in atrial fibrillation and advanced chronic kidney disease.

  • News

    Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk

    October 2, 2017

    Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.

  • 1
    Article

    Idle intravenous catheters are associated with preventable complications

    December 15, 2016

    Intravenous catheters are common and necessary for inpatient care, but peripheral – and especially central venous – catheters are associated with increased risk for local and systemic complications.

  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences